These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9274854)

  • 21. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4 mimics as HIV entry inhibitors: lead optimization studies of the aromatic substituents.
    Narumi T; Arai H; Yoshimura K; Harada S; Hirota Y; Ohashi N; Hashimoto C; Nomura W; Matsushita S; Tamamura H
    Bioorg Med Chem; 2013 May; 21(9):2518-26. PubMed ID: 23535561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
    Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
    Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
    Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
    Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion.
    Gallo SA; Reeves JD; Garg H; Foley B; Doms RW; Blumenthal R
    Retrovirology; 2006 Dec; 3():90. PubMed ID: 17144914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the site in CD4 that binds to the HIV envelope glycoprotein.
    Brodsky MH; Warton M; Myers RM; Littman DR
    J Immunol; 1990 Apr; 144(8):3078-86. PubMed ID: 1691226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bathophenanthroline disulfonate and soluble CD4 as probes for early events of HIV type 1 entry.
    Demaria S; Tilley SA; Pinter A; Bushkin Y
    AIDS Res Hum Retroviruses; 1995 Jan; 11(1):127-39. PubMed ID: 7734186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4 activation of HIV fusion.
    Sattentau QJ
    Int J Cell Cloning; 1992 Nov; 10(6):323-32. PubMed ID: 1281202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.
    Wu Z; Cocchi F; Gentles D; Ericksen B; Lubkowski J; Devico A; Lehrer RI; Lu W
    FEBS Lett; 2005 Jan; 579(1):162-6. PubMed ID: 15620707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
    Xiao X; Kinter A; Broder CC; Dimitrov DS
    Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular docking guided structure based design of symmetrical N,N'-disubstituted urea/thiourea as HIV-1 gp120-CD4 binding inhibitors.
    Sivan SK; Vangala R; Manga V
    Bioorg Med Chem; 2013 Aug; 21(15):4591-9. PubMed ID: 23777826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycodelins.
    Seppälä M; Bohn H; Tatarinov Y
    Tumour Biol; 1998; 19(3):213-20. PubMed ID: 9591048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Hydroxyphthaloyl beta-lactoglobulin. III. Antiviral activity against herpesviruses.
    Neurath AR; Strick N; Li YY
    Antivir Chem Chemother; 1998 Mar; 9(2):177-84. PubMed ID: 9875389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in targeting HIV-1 entry.
    Ryser HJ; Flückiger R
    Drug Discov Today; 2005 Aug; 10(16):1085-94. PubMed ID: 16182193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An immunoglobulin fusion protein based on the gp120-CD4 receptor complex potently inhibits human immunodeficiency virus type 1 in vitro.
    Vu JR; Fouts T; Bobb K; Burns J; McDermott B; Israel DI; Godfrey K; DeVico A
    AIDS Res Hum Retroviruses; 2006 Jun; 22(6):477-90. PubMed ID: 16796521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immunodeficiency virus type 1 entry into murine cell lines and lymphocytes from transgenic mice expressing a glycoprotein 120-binding mutant mouse CD4.
    Wieder KJ; Chatis P; Boltax J; Wieder I; Nuovo G; Strom TB
    AIDS Res Hum Retroviruses; 1996 Jul; 12(10):867-76. PubMed ID: 8798971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD4 mimics targeting the mechanism of HIV entry.
    Yamada Y; Ochiai C; Yoshimura K; Tanaka T; Ohashi N; Narumi T; Nomura W; Harada S; Matsushita S; Tamamura H
    Bioorg Med Chem Lett; 2010 Jan; 20(1):354-8. PubMed ID: 19926478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relaxin stimulates glycodelin mRNA and protein concentrations in human endometrial glandular epithelial cells.
    Tseng L; Zhu HH; Mazella J; Koistinen H; Seppälä M
    Mol Hum Reprod; 1999 Apr; 5(4):372-5. PubMed ID: 10321810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple forms of messenger ribonucleic acid encoding glycodelin in male genital tract.
    Koistinen H; Koistinen R; Kämäräinen M; Salo J; Seppälä M
    Lab Invest; 1997 May; 76(5):683-90. PubMed ID: 9166287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycodelin A triggers T cell apoptosis through a novel calcium-independent galactose-binding lectin activity.
    SundarRaj S; Soni C; Karande AA
    Mol Immunol; 2009 Oct; 46(16):3411-9. PubMed ID: 19683346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.